Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors
CORAL GABLES, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced the...
Staff
Xenon to Report Q2 2025 Financial Results on August 11, 2025
VANCOUVER, British Columbia and BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company...
Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity
DURHAM, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in...
BioAtla to Announce Second Quarter 2025 Financial Results and Provide Business Highlights on August 7, 2025
SAN DIEGO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the...
LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services,...
INmune Bio’s CaRe PC Trial of INKmune™ in Metastatic Castration-Resistant Prostate Cancer Meets Endpoints and Is Closed to Enrollment
BOCA RATON, FL, Aug. 04, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage immunology and...
Connect Appoints James Zanewicz as Chief Executive Officer to Shape the Next Chapter of Innovation Growth
SAN DIEGO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Connect, the premier nonprofit organization in the San Diego innovation ecosystem established...
Praxis Precision Medicines Announces Positive, Best-in-Disease Topline Results in Patients with Focal Onset Seizures from the RADIANT Study of Vormatrigine
Dosing with vormatrigine over 8 weeks led to 56.3% median reduction in seizure frequency Approximately 22% of patients reached 100%...
Belite Bio to Host Webcast on August 11, 2025, to Discuss Second Quarter 2025 Financial Results
SAN DIEGO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on...
ARS Pharmaceuticals Announces Conference Call and Webcast for its Second Quarter 2025 Financial Results
SAN DIEGO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk...
Akebia Initiates Vafseo® (vadadustat) Post-Marketing Study in Conjunction with Large Dialysis Organization
VOCAL, an open-label active-controlled study, is being conducted at DaVita dialysis clinics to evaluate benefits of treating patients with Vafseo...
Mural Oncology Announces Second Quarter Financial Results and Provides Business Update
Mural continues to explore strategic alternatives Estimates cash and cash equivalents of approximately $43 to $48 million at December 31,...
Glass House Brands Provides Updates to Recent Events
LONG BEACH, Calif. and TORONTO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company”)...
Medicus Pharma Ltd. Announces a Memorandum of Understanding (MOU) with Helix Nanotechnologies Inc. to Develop Thermostable Infectious Disease Vaccines
The MOU intends to combine proprietary mRNA vaccine platform of HelixNano with proprietary Microneedle array (MNA) delivery platform of Medicus.Philadelphia,...
CAS SciFinder integrates transformative new science-smart AI capabilities to enhance R&D efficiency and boost innovation
Pioneering solution provides scientists with actionable answers faster to accelerate scientific discovery COLUMBUS, Ohio, Aug. 4, 2025 /PRNewswire/ -- CAS,...
Zepp Health Corporation Reports Second Quarter 2025 Unaudited Financial Results
MILPITAS, Calif., Aug. 3, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today announced its unaudited...
United Imaging Teases Multi-modality “Provider Success” Product Launches at AHRA 2025
The newly FDA-cleared uMR® Ultra and the uOmniscan™ are the first major announcements leading into the AHRA Annual Meeting in Las...
Healthcare Leaders Address Economic, Regulatory, and Sustainability Challenges Ahead of AHRMM25
Insights from Black Book's 12th Annual Healthcare Supply Chain and Purchasing Technology Leadership Surveys DENVER, CO / ACCESS Newswire /...
Top Client-Rated Healthcare Supply Chain Tech Vendors Announced Ahead of AHRMM25 Conference
30 Category Leaders named in Black Book Research's 12th Annual Healthcare Supply Chain Management User Surveys DENVER, CO / ACCESS...
My LA Therapy Guarantees the Perfect Match for “Therapy Near Me” Searches
Offering scientifically backed therapy and couples counseling across Los Angeles and via teletherapy statewide, My LA Therapy matches clients with the...